Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. We invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. We invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. Our team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.
Pivotal bioVenture Partners supports teams that develop therapeutics that make a difference in patients' lives. Are you one of those teams? We'd love to hear from you.